Know every physician.

Reach every patient.

Know every physician.

Reach every patient.

Know every physician.

Reach every patient.

Know every physician.

Reach every patient.

Know every physician.

Reach every patient.

Know every physician.

Reach every patient.

Know every physician.

Reach every patient.

Spellbinder is the physician intelligence layer for clinical trials, medical affairs, and commercial teams. Finished work, not data to analyze or tools to operate.

Spellbinder is the physician intelligence layer for clinical trials, medical affairs, and commercial teams. Finished work, not data to analyze or tools to operate.

Book a demo →

Book a demo →

Spellbinder is physician intelligence for biopharma. Your patients have physicians. We find and engage them, from first trial to commercial launch, done for you.

Spellbinder is physician intelligence for biopharma. Your patients have physicians. We find and engage them, from first trial to commercial launch, done for you.

Spellbinder is physician intelligence for biopharma. Your patients have physicians. We find and engage them, from first trial to commercial launch, done for you.

Spellbinder is physician intelligence for biopharma. Your patients have physicians. We find and engage them, from first trial to commercial launch, done for you.

Spellbinder is physician intelligence for biopharma. Your patients have physicians. We find and engage them, from first trial to commercial launch, done for you.

Clinical teamsuse Spellbinder for
Engaging Physicians
Tracking Relationships
Simulating Physician Engagement
Investigator Identification
Patient Recruitment
Site Activation
KOL Identification

Powering the entire drug lifecycle

Smart Targeting

The right physicians, delivered to you

The right physicians, delivered to you

The right physicians, delivered to you

The right physicians, delivered to you

The right physicians, delivered to you

We deliver the ranked list, you don't build it. For clinical teams, physicians are ranked by patient population match. For medical affairs, by peer-network position and scientific influence. For commercial, by conversion potential. No SQL to write. No vendor data to reconcile. No "Early Adopter" taxonomy to maintain. The list is ready when your team arrives at work.

Targeting accuracy. Sales teams prioritize physicians by conversion potential and receptiveness to new treatments.

Targeting accuracy. Sales teams prioritize physicians by conversion potential and receptiveness to new treatments.

Targeting accuracy. Sales teams prioritize physicians by conversion potential and receptiveness to new treatments.

Targeting accuracy. Sales teams prioritize physicians by conversion potential and receptiveness to new treatments.

Targeting accuracy. Sales teams prioritize physicians by conversion potential and receptiveness to new treatments.

96%

10 physicians identified today
Tap to view your day's targets · 88 miles total
now

Today

7 visits · 88 miles

Dr. Alex M Vera

Urology
First VisitEarly Adopter
Memorial Sloan Kettering (18 miles)
Strategic first visit — Recent publication creates conversion opportunity

Dr. Richard Lang

Internal Medicine
First VisitKey Opinion Leader
AHF Healthcare Centers (10 miles)
High-volume KOL with exceptional pharma engagement

Dr. Jane Green

Internal Medicine — Infectious Disease
First VisitKey Opinion Leader
Midtown Medical Associates (9 miles)
Discovery phase — Establish credibility and assess interest

Dr. Karim Mohammed

Internal Medicine — Infectious Disease
Third VisitKey Opinion Leader
Bellevue Hospital Center (12 miles)
Follow-up visit — Strong relationship, expand product discussion

Complete Context

Every physician,
briefed.

Every physician,
briefed.

Every physician,
briefed.

Every physician,
briefed.

Every physician,
briefed.

Every name on your list comes with a complete dossier, prescribing trends, clinical trial history, publications, industry relationships, hospital affiliations, and peer networks. The same dossier serves every team. A CRC screening referring investigators, an MSL preparing for scientific exchange, a rep heading into call prep, one source of truth, delivered fresh.

Updated in real time from 400+ public datasets. Zero integration with your internal systems required.

Updated in real time from 400+ public datasets. Zero integration with your internal systems required.

Updated in real time from 400+ public datasets. Zero integration with your internal systems required.

1.2M+

Dr. Alex Vera

Dr. Alex M Vera

Urology
Early Adopter
Memorial Sloan Kettering
Dr. Alex M Vera is a Urology specialist at Memorial Sloan Kettering, NYC. Medicare panel of ~404 beneficiaries. Therapeutic focus spans Endocrine/Metabolic, Nephrology/Urology, and Oncology — with documented disease-state coverage across hypogonadism, prostate cancer, and erectile dysfunction.

Therapeutic Areas

  • Endocrine/Metabolic
  • Nephrology/Urology
  • Oncology

Top Disease States

  • Hypogonadism
  • Prostate Cancer
  • Penile Cancer
  • Chronic Pain
  • Diabetes Mellitus

Procedures/Injectables

YearCPT/HCPCSProcedure NameVolumePatientsMedicare AllowedMedicare Paid
202399214Established patient office or other outpatient visit, 30-39 minutes149141$12,248.28$9,798.62
202399204New patient office or other outpatient visit, 45-59 minutes104104$10,279.14$8,223.31
202399213Established patient office or other outpatient visit, 20-29 minutes4847$2,770.24$2,216.19
202393980Complete ultrasound of penis artery and vein blood flow3232$1,595.61$1,276.49

Drugs

YearDrugGenericScriptsPatientsDays of SupplyTotal Drug Cost
2023TestosteroneTestosterone30121,670$6,959.72
2023Testosterone CypionateTestosterone Cypionate31191,329$1,115.94
2023ClomidClomiphene Citrate120624$921.43

Year-over-year payments

$45K
2013
$128K
2014
$23K
2015
$85K
2016
$26K
2017
$236
2018
$145
2019
$2K
2020
$59
2021
$8K
2022
$658
2023
$22K
2024

Top Companies

CompanyTotal AmountTop ProductsPayment Type
Pfizer Inc.$80,141.42VIAGRA, CAVERJECTConsulting, Speaker, Travel
Auxilium Pharmaceuticals$58,837.23XIAFLEX, STENDRA, TESTIMConsulting, Speaker, Travel
Mylan Inc.$20,719.10VIAGRAConsulting, Travel
Endo Pharmaceuticals$15,243.62XIAFLEX, AVEED, TESTOPELConsulting, Food and Beverage
Lilly USA, LLC$15,474.97CIALISConsulting, Travel
AbbVie, Inc.$12,990.02Androgel, Humira, LupronConsulting

Active & Completed Trials

StudyNCT IDPhaseRoleStatusSponsor
Enzalutamide + Leuprolide in Nonmetastatic Prostate Cancer (EMBARK)NCT02319837Phase 3InvestigatorActiveAstellas / Pfizer
Tadalafil After Radical Prostatectomy (REACTT)NCT01026818Phase 4Publication AuthorCompletedEli Lilly and Company
Avanafil for ED Post-ProstatectomyNCT00895011Phase 3Study DirectorCompletedVIVUS LLC
Pharmacological Penile Rehabilitation After Bilateral Nerve-Sparing RPNCT00955929NAPrincipal InvestigatorTerminatedMemorial Sloan Kettering
Prograf in the Prevention of ED After Radical ProstatectomyNCT00106392Phase 4Publication AuthorCompletedAstellas Pharma Inc

PubMed Selected Publications

  • Freedland SJ, Vera AM, Gleave M, et al. Effects of Enzalutamide on Sexual Activity in Biochemically Recurrent Prostate Cancer: A Post Hoc Analysis of EMBARK.
    European Urology · 2025 · Prostatic Neoplasms, Sexual Behavior
  • Nascimento BCG, Vera AM, et al. Prospective study of endogenous testosterone recovery following neoadjuvant hormonal blockade and radical prostatectomy.
    Journal of Sexual Medicine · 2025 · Testosterone, Prostatectomy
  • Vera AM, Klein EA, Slawin K, et al. A Randomized, Double-Blind, Placebo-Controlled Trial of Tacrolimus for the Prevention of ED Following Bilateral Nerve-Sparing Radical Prostatectomy.
    Journal of Sexual Medicine · 2018 · Erectile Dysfunction
  • Vera AM, Brock G, Oelke M, et al. Effects of Tadalafil Once-Daily vs Placebo on Return to Baseline Erectile Function After Radical Prostatectomy (REACTT).
    Journal of Sexual Medicine · 2016

Complete Context

Every physician,
briefed.

Every name on your list comes with a complete dossier, prescribing trends, clinical trial history, publications, industry relationships, hospital affiliations, and peer networks.


The same dossier serves every team. A CRC screening referring investigators, an MSL preparing for scientific exchange, a rep heading into call prep, one source of truth, delivered fresh.

1.2M+

Physician profiles with prescribing data, clinical trials, publications, and professional networks. Updated in real-time.

Physician dossiers include

1,231,982 physician records • Updated in real-time

Prescribing Patterns

See exactly which treatments they're prescribing, how often, and for how many patients. Track monthly trends and generic vs branded preferences that reveal their prescribing philosophy.

Clinical Practice

Understand their patient volume, subspecialties, hospital affiliations, and practice context. Know the environment they work in before your first conversation.

Research Activity

Access their complete clinical trial history and active studies. Their research focus shows you exactly what therapeutic problems matter most to them.

Professional Network

Know which companies already have their attention through speaking fees, consulting roles, and advisory boards. Identify competitive dynamics and white space opportunities.

Publications

Read their recent work to understand their clinical perspectives and treatment philosophies. Each paper reveals what evidence resonates with them.

Physician dossiers include

1,231,982 physician records • Updated in real-time

Prescribing Patterns

See exactly which treatments they're prescribing, how often, and for how many patients. Track monthly trends and generic vs branded preferences that reveal their prescribing philosophy.

Clinical Practice

Understand their patient volume, subspecialties, hospital affiliations, and practice context. Know the environment they work in before your first conversation.

Research Activity

Access their complete clinical trial history and active studies. Their research focus shows you exactly what therapeutic problems matter most to them.

Professional Network

Know which companies already have their attention through speaking fees, consulting roles, and advisory boards. Identify competitive dynamics and white space opportunities.

Publications

Read their recent work to understand their clinical perspectives and treatment philosophies. Each paper reveals what evidence resonates with them.

Physician dossiers include

1,231,982 physician records • Updated in real-time

Prescribing Patterns

See exactly which treatments they're prescribing, how often, and for how many patients. Track monthly trends and generic vs branded preferences that reveal their prescribing philosophy.

Clinical Practice

Understand their patient volume, subspecialties, hospital affiliations, and practice context. Know the environment they work in before your first conversation.

Research Activity

Access their complete clinical trial history and active studies. Their research focus shows you exactly what therapeutic problems matter most to them.

Professional Network

Know which companies already have their attention through speaking fees, consulting roles, and advisory boards. Identify competitive dynamics and white space opportunities.

Publications

Read their recent work to understand their clinical perspectives and treatment philosophies. Each paper reveals what evidence resonates with them.

Physician dossiers include

1,231,982 physician records • Updated in real-time

1,231,982 physician records • Updated in real-time

Prescribing Patterns

See exactly which treatments they're prescribing, how often, and for how many patients. Track monthly trends and generic vs branded preferences that reveal their prescribing philosophy.

Clinical Practice

Understand their patient volume, subspecialties, hospital affiliations, and practice context. Know the environment they work in before your first conversation.

Research Activity

Access their complete clinical trial history and active studies. Their research focus shows you exactly what therapeutic problems matter most to them.

Professional Network

Know which companies already have their attention through speaking fees, consulting roles, and advisory boards. Identify competitive dynamics and white space opportunities.

Publications

Read their recent work to understand their clinical perspectives and treatment philosophies. Each paper reveals what evidence resonates with them.

Conversion Intelligence

Every meeting, prepared.

Every meeting, prepared.

Every meeting, prepared.

Every meeting, prepared.

Every meeting, prepared.

Every interaction comes with a personalized brief. For CRCs, the eligibility questions match this physician's patient mix. For MSLs, the open scientific questions this KOL has been asking. For reps, the efficacy data this prescriber cares about, with objections anticipated. The briefs refine themselves as you build the relationship. Every conversation gets smarter.

Higher conversion rates by matching treatments to physician profiles and anticipating objections before they happen.

Higher conversion rates by matching treatments to physician profiles and anticipating objections before they happen.

Higher conversion rates by matching treatments to physician profiles and anticipating objections before they happen.

2.3x

Our Mission

Conversion Intelligence

Bring cures to market faster.

Bring cures to market faster.

Bring cures to market faster.

Bring cures to market faster.

Bring cures to market faster.

We're building toward a world where no patient waits months for a treatment that could save their life. Where when a breakthrough happens anywhere in medicine, every relevant physician knows about it immediately.

A patient diagnosed with aggressive cancer won't lose precious weeks while their doctor learns about the treatment that could help them. Commercial success will happen faster, funding more R&D, creating more breakthroughs.

We're building toward a world where no patient waits months for a treatment that could save their life. Where when a breakthrough happens anywhere in medicine, every relevant physician knows about it immediately.

A patient diagnosed with aggressive cancer won't lose precious weeks while their doctor learns about the treatment that could help them. Commercial success will happen faster, funding more R&D, creating more breakthroughs.

Testimonials

Trusted by experts at pharmaceutical companies

"Our coordinators had spent a month finding one physician. Spellbinder gave us three in forty-eight hours. We signed before the contract was drafted."

Clinical Operations Lead

Clinical-stage Biopharma

01 / 04